Effects of Cuprizone on Dopaminergic Neurons in Rats
Cuprizone treatment in rats resulted in reduced firing rates of dopaminergic neurons in the rVTA, decreased excitatory synaptic activity, and increased excitability in pyramidal neurons within the mPFC. This treatment also led to working memory deficits while leaving other cognitive tasks unaffected.
- Tags
- #MSResearch
- Most relevant to
- —
Why it matters
Understanding these changes in dopaminergic function and cognition may provide insights into mechanisms underlying cognitive deficits in multiple sclerosis.
What this does not prove
The findings are based on an animal model and do not directly translate to human MS. Moreover, there is limited evidence directly linking dopamine dysfunction in the prefrontal cortex to MS-related cognitive issues.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-09-23
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceMesocortical dopamine hypofunction and prefrontal plasticity deficits in the cuprizone model. ↗DOI: 10.1016/j.nbd.2026.107617
Supporting passages (4)
publication datePublication date: 2026-09-23
interventionAfter six weeks of 1% cuprizone administration, we combined ex vivo electrophysiology in the rostral ventral tegmental area (rVTA) and medial PFC (mPFC), in vivo microdialysis of extracellular dopamine in the mPFC, behavioral assessment of cognition and anxiety-like behavior, gait analysis, and plasma corticosterone measurements.
findingsCuprizone reduced the spontaneous firing rate of rVTA dopaminergic neurons and decreased glutamatergic miniature excitatory postsynaptic current frequency.
limitationsHowever, direct experimental evidence linking prefrontal dopamine dysfunction to MS-related cognitive deficits is limited.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.